Latest News

HIAG Immobilien Holding FY 2025 earnings snapshot HIAG Immobilien Holding (SWX:HIAG) has just posted its FY 2025 numbers, with first half revenue of CHF 47.6 million and basic EPS of CHF 4.42, while funds from operations came in at CHF 1.90 per share, giving investors a fresh read on both cash generation and headline profitability. Over recent periods the company has seen revenue move from CHF 70.3 million in the first half of 2024 to CHF 65.8 million in the second half of 2024 and then to...

Idun Industrier (OM:IDUN B) has wrapped up FY 2025 with Q4 revenue of SEK627.1 million and basic EPS of SEK0.50, capping a trailing twelve month run that produced SEK2.3 billion in revenue and EPS of SEK4.69. Over the last few quarters, the company has seen revenue move from SEK567.2 million in Q4 2024 to SEK627.1 million in Q4 2025, while quarterly EPS shifted from SEK0.03 to SEK0.50. This gives investors a basis to weigh improving profit levels against still modest net margins. See our full...

Yancoal Australia (ASX:YAL) has drawn fresh investor attention after releasing its 2025 results. The company reported a combination of higher coal production with lower revenue and net income, and confirmed a final A$161 million dividend for the year. See our latest analysis for Yancoal Australia. Yancoal Australia’s recent earnings release and confirmed dividend have arrived alongside a strong run in the shares, with a 26.55% year to date share price return and a very large 5 year total...

What Holcim’s 2025 earnings mean for shareholders Holcim (SWX:HOLN) has moved into focus after reporting full year 2025 results, with sales of CHF 15,724 million compared to CHF 16,201 million a year earlier, and a sharp jump in reported net income and earnings per share. See our latest analysis for Holcim. Despite the strong headline earnings, Holcim’s 1 month share price return of an 18.15% decline and a 14% share price pullback year to date suggest momentum has cooled, even as the 1 year...

Protagonist Therapeutics stock: recent move puts biotech name on investor radar Protagonist Therapeutics (PTGX) has drawn fresh interest after recent share price strength, with the stock last closing at US$94.83 and showing double digit gains over the past month and past 3 months. See our latest analysis for Protagonist Therapeutics. The recent 14.2% 1 month share price return and 8.8% year to date share price return sit alongside a very strong 1 year total shareholder return of 146.6%,...

In February 2026, Boyd Gaming announced the upcoming retirement of Chief Administrative Officer Stephen Thompson and raised its quarterly dividend from US$0.18 to US$0.20 per share, payable on April 15, 2026, to shareholders of record on March 16, 2026. This combination of leadership change and a dividend increase highlights management’s focus on capital returns while maintaining continuity in the company’s broader operating and financial approach. Next, we’ll examine how Boyd Gaming’s...

Cboe Global Markets reported record-breaking trading volumes across its global business lines in February. The company set monthly average daily volume records in its proprietary index options. Cboe also reported new highs in trading activity across its European trading operations. Cboe Global Markets, ticker BATS:CBOE, is drawing fresh attention after reporting record trading volumes in February, with new highs in its index options and European operations. The stock last closed at $300.62,...

Kyndryl Holdings (NYSE:KD) has been hit with multiple securities class action lawsuits following disclosures of material weaknesses in its internal controls. The company also reported the departures of key executives, including its Chief Financial Officer and General Counsel. Investors are assessing what these control issues and leadership changes could mean for financial reporting quality and potential legal exposure. Kyndryl Holdings, trading at about $13.14, has seen sharp volatility,...

If you are wondering whether BWG's share price still offers value after a strong run, this article walks through what the current valuation actually implies for investors. BWG recently closed at NOK168.80, with returns of 11.6% over the past 30 days, 32.2% year to date, 57.1% over 1 year, 218.5% over 3 years, and a very large gain over 5 years of more than 7x. Recent news coverage around BWG has focused on the stock's sustained performance over multi year periods and what that might mean for...

If you have ever wondered whether Netflix's share price really reflects what you are paying for, this breakdown will help you separate story from numbers. Netflix closed at US$98.66, with returns of 16.6% over the past week, 23.4% over the past month, 8.4% year to date, 8.9% over one year, and a very large return over three years that is described as 231.3% and 88.6% over five years. Recent headlines around Netflix have continued to focus on its position in global streaming and its efforts...

Recent trading performance Aktis Oncology (AKTS) has drawn fresh attention after recent share price moves, with the stock up 3.1% over the past day and 6.9% over the past week, despite a 5.1% decline over the past month. For context, the Boston based clinical stage company focuses on targeted radiopharmaceutical therapies. It reported US$5.56 in revenue and a net loss of US$60.649, while shares most recently closed at US$20.85. See our latest analysis for Aktis Oncology. That recent 1-day and...

If you are wondering whether Johnson & Johnson is trading at a fair price today, you are not alone. The mix of a strong brand and changing headlines has many investors asking what the stock is really worth. Over the past week the share price return was 0.1%. Over the last month it was 6.3%. Year to date it was 18.3%. Over 1 year and 5 years the returns were 52.7% and 77.5% respectively, which can affect how much upside or downside investors feel is left in the story. Recent news around...

Wondering whether Tyler Technologies at US$368.16 is starting to look interesting on value, or if the price still feels a bit rich for what you are getting. The stock has moved 9.9% over the last 7 days and 1.5% over 30 days, while the year to date return sits at a 15.5% decline and the 1 year return at a 41.1% decline, with a 12.7% 3 year return and an 8.1% decline over 5 years. These mixed returns mean recent news and sentiment matter for how investors are looking at Tyler Technologies...

In early March 2026, Alignment Healthcare filed an omnibus shelf registration and a selling stockholder completed a US$256.24 million secondary offering of 13,167,733 common shares at US$19.46 each under that shelf. These transactions, alongside the company’s strong 2025 results and upbeat 2026 revenue and EBITDA guidance, highlight rising investor interest despite no new capital going to Alignment itself. We’ll now examine how this secondary offering by a major shareholder, paired with...

Buckle (BKE) just released its latest 4 week sales update, reporting comparable store net sales up 8.0% and total net sales rising 8.8% to US$84.4 million for the period. See our latest analysis for Buckle. At a share price of US$53.0, Buckle has recently seen a 10.1% 1 month share price return. Its 1 year total shareholder return of 52.9% and 5 year total shareholder return of 124.0% point to strong longer term gains, suggesting recent sales updates may be reinforcing momentum after some...

Earnings and collaboration put Tango Therapeutics (TNGX) in focus Tango Therapeutics (TNGX) is drawing fresh attention after reporting its fourth quarter and full year 2025 results, alongside a new clinical trial collaboration with Erasca that combines two targeted agents for MTAP-deleted cancers. See our latest analysis for Tango Therapeutics. The earnings update and new Erasca collaboration come after a strong run, with Tango’s 90 day share price return of 24.75% and a very large 1 year...

Viavi Solutions (VIAV) is back on investors' radar after a sharp stock move tied to fresh analyst confidence, management commentary on end markets, and new wins in AI driven networking and optical testing. See our latest analysis for Viavi Solutions. Those AI and 6G projects have landed at a time when momentum in the stock has clearly picked up. A 30 day share price return of 27.35% has fed into a 90 day share price return of 86.23% and a 1 year total shareholder return of 188.66%. This...

Universal Music Group (ENXTAM:UMG) is in focus as investors weigh an imminent Q4 2025 earnings release alongside a proposed final dividend of €0.28 per share for 2025, pending shareholder approval. See our latest analysis for Universal Music Group. At a share price of €19.36, Universal Music Group has seen a 2.57% 1 day share price return and a 2.87% 7 day share price return. The year to date share price return of 11.80% and 1 year total shareholder return of 23.99% indicate that recent...

Why this Dunkirk investment matters for ArcelorMittal shares ArcelorMittal (ENXTAM:MT) has put a €1.3b electric arc furnace project in Dunkirk at the center of its decarbonization plan, supported by EU policy proposals and long term low carbon power contracts. See our latest analysis for ArcelorMittal. The Dunkirk investment comes at a time when ArcelorMittal’s share price has pulled back, with a 1 day share price return of a 6.79% decline and a 7 day return of an 11.41% decline. However, the...

Genius Sports (GENI) has just posted another loss making quarter, with Q3 FY 2025 revenue of US$166.3 million and a basic EPS loss of US$0.11 as the company continues to push for scale in sports data and betting technology. Over recent periods, revenue has moved from US$95.4 million in Q2 2024 to US$120.2 million in Q3 2024 and US$166.3 million in Q3 2025, while quarterly EPS has swung between a profit of US$0.05 in Q3 2024 and losses of US$0.12 in Q4 2024, US$0.03 in Q1 2025, US$0.21 in Q2...

Why Synsam’s latest earnings, buybacks and dividend matter for shareholders Synsam (OM:SYNSAM) has just wrapped up a busy period, combining fourth quarter and full year 2025 results with completed share buybacks and a proposed cash dividend, all of which directly affect shareholder value. For the fourth quarter of 2025, Synsam reported sales of SEK 1,784 million and revenue of SEK 1,834 million, compared with SEK 1,631 million and SEK 1,659 million respectively a year earlier. Net income for...

First Bancorp (FBNC) is drawing attention after president and CEO Michael G. Mayer retired effective February 28, 2026, while remaining on the board, alongside new board responsibilities for Adam Currie and an analyst rating upgrade. See our latest analysis for First Bancorp. At a share price of US$58.12, First Bancorp’s recent 7 day and 30 day share price returns have been slightly negative, while its 90 day gain of 12.61% and 1 year total shareholder return of 46.85% suggest momentum has...

Dividend, profit return and board change put Domino's Pizza Enterprises (ASX:DMP) in focus Domino's Pizza Enterprises (ASX:DMP) has returned to a half year net profit, reinstated a A$0.25 per share cash dividend, and added experienced quick service restaurant executive Drew O’Malley to its board. See our latest analysis for Domino's Pizza Enterprises. Even with the return to profit, the reinstated dividend and the appointment of Drew O’Malley, the 30 day share price return of 22.79% and 1...

In recent days, multiple major banks and research firms have initiated upbeat coverage on newly public Forgent Power Solutions, which raised about US$1.50 billion in its IPO and focuses on electrical distribution equipment for data centers, utilities, and industrial customers. What makes this coverage stand out is the rare alignment of Wall Street analysts and high-profile media voices highlighting Forgent’s ability to supply engineered, end-to-end powertrain solutions to an...